Polyglucose and amino acids: Preliminary results

Peritoneal Dialysis International

Volumn 17, Issue SUPPL. 2, 1997, Pages

  Faller, Bernadette ^a,c   Shockley, Ty ^b   Genestier, Sandrine ^a   Martis, Leo ^b  

^a Civil Hospital   (France)

^b BAXTER HEALTHCARE CORPORATION   (United States)

^c Pasteur Hospital   (France)

Author keywords

Amino acids; Osmotic agents; Polyglucose

Indexed keywords

AMINO ACID; CREATININE; GLUCOSE POLYMER; UREA;

ADULT; AMINO ACID BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; BODY TEMPERATURE; BODY WEIGHT; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; GLUCOSE ABSORPTION; HUMAN; MALE; OSMOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAFETY; ULTRAFILTRATION;

EID: 0030832624     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089701702s12     Document Type: Conference Paper

References (19)

1. Rippe B, Krediet R. Peritoneal physiology-transport of solutes. In: Gokal R, Nolph KD, eds. The textbook of peritoneal dialysis. Dordrecht, the Netherlands: Kluwer Academic Publishers, 1994; 69-113.
2. Nolph KD, Miller FN, Pyle WK, Popovich RP, Sorkin MT. An hypothesis to explain the ultrafiltration characteristics of peritoneal dialysis. Kidney Int 1981; 20:543-8.
3. Twardowski ZJ, Khanna R, Nolph KD. Osmotic agents and ultrafiltration in peritoneal dialysis. Nephron 1986; 42:93-100.
4. Mistry CD, Mattick NP, Gokal R. Ultrafiltration with an iso-osmotic solution during long peritoneal dialysis exchanges. Lancet 1987; ii:178-82.
5. Mistry CD, Gokal R, Peers E and the MIDAS study group. A randomized multicenter clinical trial comparing isosmolar Icodextrin with hyperosmolar glucose solutions in CAPD. Kidney Int 1994; 46:496-503.
6. Mistry CD, Gokal R. Alternative osmotic agents. Blood Purif 1989; 7:109-14.
7. Faller B, Burke R, De Leo M, Shockley TR, Martis L. Use of maltodextrins and amino acids as alternate osmotic agents for PD. Pent Dial Int 1994; 14(Suppl 1):S23.
8. Kopple JD, Bernard D, Messana J, et al. Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int 1995; 47:1148-57.
9. Faller B. Amino acid-based peritoneal dialysis solutions. Kidney Int 1996; 50 (Suppl 56):S81-5.
10. Krediet RT, Struijik DG, Koomen GCM, Arisz L. Peritoneal kinetics during CAPD measured with intraperitoneal Dextran 70. Trans Am Soc Artif Intern Organs 1991; 37:662-7.
11. Burke RA, Hvlzd MG, Shockley TR. Direct determination of polyglucose metabolises in plasma using anion exchange chromatography with pulsed amperometric detection. J Chroma 1997. In press.
12. Mistry CD, Bhowmick B, Ashman R, Uttley L. Clinical studies of new icodextrin formulations. Perit Dial Int 1994; 14 (S2):S55-7.
13. Peers EM, Scrimgeour AC, Haycox AR. Cost-containment in CAPD patients with ultrafiltration failure. Clin Drug Invest 1995; 10:53-8.
14. Millar DJ. Glycation of albumin with icodextrin (Abstract). J Am Soc Nephrol 1995; 6:551.
15. Williams PF, Marliss EB, Oren A, et al. Amino acid absorption following intraperitoneal administration in CAPD patients. Perit Dial Bull 1982; 2:129-30.
16. Young GA, Dibble JB, Hobon SM, et al. The use of an amino-acid based CAPD fluid over 12 weeks. Nephrol Dial Transplant 1989; 4:285-92.
17. Hohnes CJ. Biocompatibility of peritoneal dialysis solutions. Perit Dial Int 1993; 13:88-94.
18. De Fijter CWH, Verbrugh HA, Peters EDJ, et al. In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD. Clin Nephrol 1993; 39:75-80.
19. Gokal R, Mistry CD, Peers E and the Midas study group. Peritonitis occurrence in a multicenter study of icodextrin and glucose in CAPD. Perit Dial Int 1995; 15:226-30.